— Know what they know.
Not Investment Advice

CDXC NASDAQ

ChromaDex Corporation
1W: +9.2% 1M: -21.7% 3M: +16.7% 1Y: +50.1% 3Y: +148.6% 5Y: +76.4%
$7.87
Last traded 2025-04-14 — delisted
NASDAQ · Healthcare · Biotechnology · $611.9M mcap · 51M float · 1.59% daily turnover · Short 36% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$0 -100.0% ▼
Gross Profit
$83M +35.1% ▲
5Y CAGR: +18.7%
Operating Income
$16M +110.7% ▲
Net Income
$17M +103.3% ▲
EPS (Diluted)
$0.20 +81.8% ▲
EBITDA
$16M +76.8% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$67M$72M$84M$100M$0
YoY Growth+13.8%+6.8%+16.0%+19.2%-100.0%
Cost of Revenue$26M$29M$33M$38M$0
Gross Profit$41M$43M$51M$62M$83M
Gross Margin61.5%59.4%60.8%61.8%
R&D Expenses$4M$5M$5M$6M$6M
SG&A Expenses$65M$57M$51M$48M$63M
Operating Expenses$69M$61M$56M$54M$69M
Operating Income-$27M-$19M-$6M$8M$16M
Operating Margin-40.1%-25.9%-6.7%7.8%
Interest Expense$55K$0$0$0$0
Income Before Tax-$27M-$17M-$5M$9M$18M
Tax Expense$0$0$0$305K$810K
Net Income-$27M-$17M-$5M$9M$17M
Net Margin-40.2%-23.0%-5.9%8.6%
EPS (Diluted)$-0.40$-0.24$-0.07$0.11$0.20
EBITDA-$25M-$17M-$3M$9M$16M
Shares Outstanding67M70M75M78M85M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms